Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study

Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study

This is a single-center randomized open label active-controlled crossover trial comparing efficacy and safety of fast acting insulin aspart (FA) (FIASP®) versus insulin aspart (IAsp) (NovoLog®) when used in the Medtronic 670G system in auto mode in patients with type 1 diabetes. Forty patients were...

Full description

Bibliographic Details
Main Authors: Ahn, L.P (Author), Blevins, T.C (Author), Cooper, A.M (Author), Ozer, K. (Author), Waggonner, C.R (Author)
Format: Article
Language:English
Published: Mary Ann Liebert Inc. 2021
Subjects:
1,5 anhydrosorbitol
adult
antidiabetic agent
Article
Blood Glucose
comparative effectiveness
controlled study
crossover procedure
Cross-Over Studies
Diabetes Mellitus, Type 1
diabetic patient
double blind procedure
Double-Blind Method
drug efficacy
drug safety
Fast acting insulin aspart
female
fructosamine
glucose
glucose blood level
hemoglobin A1c
human
Humans
hypoglycemia
Hypoglycemic Agents
injection site reaction
insulin
Insulin
insulin aspart
Insulin Aspart
insulin dependent diabetes mellitus
major clinical study
male
Medtronic 670G hybrid closed loop
middle aged
occlusion
open study
randomized controlled trial
test meal
Type 1 diabetes
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items